Clinical Trials Sponsored by Alison Walker

Total 5742 results

Alison Walker

Completed

AR-42 and Decitabine in Treating Patients With Acute Myeloid Leukemia

Recurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8... and other conditions

United States
Alison Walker
Seagen Inc.

Terminated

Azacitidine and Lintuzumab in Treating Patients With Previously Untreated Myelodysplastic Syndromes

Myelodysplastic Syndromes | Leukemia

United States
Alison Walker
Novartis; Millennium Pharmaceuticals, Inc.

Completed

Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia | Recurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid... and other conditions

United States
CIBA VISION
Bascom Palmer Eye Institute

Completed

Ocular Comfort and OCT Observation of Post Lens Clearance and Ocular Tissue Compression

Ocular Comfort

United States
Alison Morris

Completed

Statins for Pulmonary and Cardiac Complications of Chronic HIV - Coordinating Center (SPARC)

HIV Seropositivity

United States
Alison Ehrlich

Completed

Topical Sodium Thiosulfate and Fractional Carbon Dioxide Laser in Treating Dermatomyositis Associated Calcinosis

Calcinosis

United States
Alison Stopeck

Recruiting

Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer

Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | TNBC, Triple Negative Breast Cancer | Locally Advanced Breast Cancer | Neoadjuvant Chemotherapy

United States
Alison Schneider

Terminated

Efficacy of Metronidazole Prophylaxis Against Clostridium Difficile-Associated Diarrhea in High Risk Adult Patients

Clostridium Difficile Diarrhea

United States
Walden University
Wake Forest University Health Sciences

Unknown

Resource Availability Following Critical Illness

Quality of Life

United States
Alison Gernand
Penn State University

Completed

Cyclic Variation in Micronutrient Concentrations and Plasma Volume

Menstrual Cycle | Plasma Volume | Micronutrients

United States
University of Guelph
Alison Duncan

Completed

Effects of Omega-3 Fatty Acids on Risk Factors for Breast Cancer in Pre-menopausal Women

Healthy | Premenopausal Period
Whitman-Walker Institute
ViiV Healthcare

Enrolling by invitation

Clinical Effectiveness-Implementation Hybrid Type 2 Study on Home-Delivered Cabenuva for People Living With HIV Who Are Not Retained in Care (CREATE)

HIV

United States
Alison Stopeck
Amgen

Completed

Denosumab and MRI Breast Imaging (Dmab)

Breast Cancer

United States
Sandra Walker

Completed

Once Daily Aminoglycoside Pharmacokinetics and Optimal Dosing in the Burn Population: A Prospective Study

Burns | Infection

Canada
Alison Fox-Robichaud

Completed

Studies of Blood DNA in Patients With Severe Infection DYNAMICS (DYNAMICS)

Sepsis | Shock | Trauma

Canada
Alison Sehgal, MD, MS

Terminated

Phase I Study of Mitoxantrone and Etoposide Combined With Hydroxychloroquine, for Relapsed Acute Myelogenous Leukemia

Leukemia, Acute Myelogenous

United States
Walter Ritter GmbH & Co

Completed

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

Erectile Dysfunction

Germany
Walter Reed Army Medical Center
Eastern Virginia Medical School; University of Virginia; James Madison University

Completed

Normal Lacritin Levels in Human Tears- Development of a New Clinical Assay

Tear Protein Lacritin in Human Tears

United States
Aligos Therapeutics

Recruiting

A Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics, and Drug-Drug Interaction Potential of Single and Multiple Doses of ALG-097558

COVID-19

United Kingdom
Aligos Therapeutics

Terminated

A Study of ALG-125755 to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics After Single Doses in Healthy Volunteers, and Single and Multiple Doses in CHB Subjects

Chronic Hepatitis B

New Zealand, Bulgaria, Moldova, Republic of, Romania
Aligos Therapeutics

Completed

A Study of ALG-055009 in Healthy Volunteers and Subjects With Hyperlipidemia

NASH - Nonalcoholic Steatohepatitis

France
Aligos Therapeutics

Terminated

A Study of ALG-020572 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single Doses in Healthy Volunteers and Multiple Doses in CHB Subjects

Chronic Hepatitis B

United Kingdom, New Zealand
Aviron LLC

Unknown

An Open Non-comparative Study of the Efficacy and Safety of Aprotinin in Patients Hospitalized With COVID-19

COVID-19

Russian Federation
Aligos Therapeutics

Recruiting

ALG-055009 in Non-cirrhotic Adults With MASH (HERALD) (HERALD)

Nonalcoholic Steatohepatitis | NASH | MASH | Metabolic Dysfunction-Associated Steatohepatitis

United States
Aligos Therapeutics

Recruiting

A Study of ALG-000184 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single and Multiple Doses in Healthy Volunteers and CHB Subjects

Chronic Hepatitis B

Hong Kong, China, United Kingdom, Moldova, Republic of, New Zealand, Australia, Mauritius
Aligos Therapeutics

Active, not recruiting

A Phase 1 Study to Evaluate the Drug-Drug Interaction Potential Between ALG-055009 and Statin Therapy(Ies)

Healthy Volunteers

United States
Aligos Therapeutics

Terminated

A Study of ALG-010133 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single and Multiple Doses in Healthy Volunteers and CHB Subjects

Chronic Hepatitis B

Korea, Republic of, China, Hong Kong, United Kingdom, New Zealand, Moldova, Republic of
Allison Gibson

Completed

Platform-based Mild Cognitive Impairment (MCI) Trial

Mild Cognitive Impairment

United States
Alison Gustafson
East Carolina University

Completed

Shopping Smart - Adolescent Intervention to Improve Shopping Practices Where You Live and Learn

Food Choices

United States
Aymes International Limited
Alison Clark Health and Nutrition

Completed

Acceptability and Tolerance Study of New Oral Nutritional Supplement

Malnutrition
Aymes International Limited
Alison Clark Health and Nutrition

Completed

Acceptability and Tolerance Study of a New Oral Nutritional Supplement (ONS)

Malnutrition
Aymes International Limited
Alison Clark Health and Nutrition

Completed

Acceptability and Tolerance of New Oral Nutritional Supplement

Malnutrition
Walden Biosciences

Completed

Single Ascending Dose Study of WAL0921 in Healthy Subjects

Healthy

United States
Wilkes University

Completed

Assessment of Analgesics and Sedatives in Mechanically Ventilated Patients With COVID-19

COVID-19 | Iatrogenic Disease | ARDS | Withdrawal Syndrome

United States
Warner Chilcott

Terminated

A Two-week Open-label Pharmacodynamic and Pharmacokinetic Study of Multiple Doses of a Darifenacin Liquid Oral Suspension in Children (2 - 15 Years) With Neurogenic Detrusor Overactivity

Neurogenic Detrusor Overactivity

United States, Colombia
Warner Chilcott

Completed

Evaluate Long-Term Safety and Efficacy WC3011 (Estradiol Vaginal Cream)

Vulvovaginal Atrophy

United States
Warner Chilcott

Completed

Safety & Efficacy WC3011 (Estradiol Vaginal Cream) in the Treatment of Vulvovaginal Atrophy in Postmenopausal Women (VENUS)

Postmenopausal Vulvovaginal Atrophy

United States
Parker University

Completed

MIST3: Active Patient Safety Reporting (MIST3)

Safety Issues

United States
Warner Chilcott

Completed

Delayed Release (DR) Risedronate Compared to Immediate Release (IR) in Postmenopausal Women

Postmenopausal Osteoporosis

United States
Warner Chilcott

Completed

Treatment of Erectile Dysfunction II

Erectile Dysfunction

United States
Warner Chilcott

Completed

Asacol Acute Diverticulitis(DIVA)Study

Diverticulitis

United States
Warner Chilcott

Completed

Study to Assess the Efficacy/Safety of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido

Hypoactive Sexual Desire Disorder (HSDD)

United States, Australia, Canada
Warner Chilcott

Completed

Pharmacokinetics of Asacol 2.4 g/Day and Lialda 2.4 g/Day in Healthy Volunteers

Healthy

United States
Warner Chilcott

Completed

Study of Transdermal Testosterone Patches in Menopausal Women With Low Libido

Hypoactive Sexual Desire Disorder

Australia
Warner Chilcott

Completed

Treatment of Chlamydia Infection Comparing WC2031 Tablets With Vibramycin

Urogential Chlamydia Trachomatis Infection

United States
Warner Chilcott

Terminated

Assessing the Safety/Efficacy of Transdermal Testosterone in Female Patients With Symptomatic Heart Failure (CORDELIA)

Heart Failure

United States
Warner Chilcott

Completed

Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day (ASCEND I) (ASCEND I)

Ulcerative Colitis

United States
Walden University

Completed

Maternal Risk Factors for Autism Spectrum Disorders: A Case-Control Approach

Pregnancy Related | Autism Spectrum Disorder | Autistic Disorder | Folate Deficiency | Folic Acid Deficiency | Diet, Healthy | Autism | Diet; Deficiency | Folic Acid Overdose

United States
Parker University

Completed

Effect of Lower Extremity Joint Manipulation on a Lower Extremity Somatosensory Illusion

Healthy | Coordination and Balance Disturbances

United States
Parker University

Completed

Nutrient Nutritional Advise for Low Back Pain Patients Seeking Chiropractic Care

Low Back Pain | Nutrition Poor

United States

Clinical Trials Sponsored by Alison Walker

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations